Total (n = 116) | LF (n = 87) | HF (n = 29) | p value | |
---|---|---|---|---|
Serum ferritin, ng/mL | 50.7 (17.5–98.8) | 30 (14.3–56.7) | 151 (117.5–218) | |
Cohort time, day | 1825 (819–1825) | 1825 (1008–1825) | 1091 (668.5–1825) | |
Age, year | 65.4 ± 13.4 | 64.8 ± 13.5 | 66.9 ± 13.3 | 0.47 |
Malea | 81 (70%) | 59 (68%) | 22 (76%) | 0.49 |
Cause of ESRD | ||||
Diabetic nephropathy | 34 (29%) | 26 (30%) | 8 (28%) | |
IgA nephropathy or chronic glomerulonephritis | 36 (31%) | 25 (29%) | 11 (38%) | |
Nephrosclerosis | 12 (10%) | 10 (11%) | 2 (6.9%) | |
Rapid progressive glomerulonephritis | 1 (0.9%) | 1 (1.1%) | 0 (0%) | |
Polycystic kidney disease | 7 (6.0%) | 6 (6.9%) | 1 (3.4%) | |
Others | 14 (12%) | 10 (11%) | 4 (14%) | |
Unknown | 12 (10%) | 9 (10%) | 3 (10%) | |
Hemoglobin, g/dL | 10.8 ± 1.15 | 10.9 ± 1.08 | 10.7 ± 1.34 | 0.49 |
Serum iron, μg/dL | 55.5 (38–73) | 54 (35–73) | 56 (45–79.5) | 0.12 |
TIBC, μg/dL | 271 (235–309) | 284 (251–318) | 234 (207–257) | < 0.001 |
T-SAT, % | 20.4 (14.8–27.3) | 17.9 (13.3–24.6) | 25.7 (19.7–34) | 0.0007 |
Intravenous irona | 27 (23%) | 21 (24%) | 6 (21%) | 0.80 |
Iron dose, mg/month | 42.1 ± 85.8 | 45.5 ± 92.1 | 31.7 ± 63.6 | 0.46 |
ESAa | 100 (86%) | 75 (86%) | 25 (86%) | 1.00 |
ESA dose, μg/week | 29.9 ± 25.1 | 30.2 ± 24.7 | 29.3 ± 26.7 | 0.87 |
HD vintage, month | 79 (32–136) | 81 (33–138) | 78 (27–124) | 0.68 |
Kt/V (single pool) | 1.40 (1.23–1.54) | 1.38 (1.25–1.53) | 1.43 (1.21–1.56) | 0.067 |
Serum creatinine, mg/dL | 11.9 ± 3.04 | 12.0 ± 3.16 | 11.5 ± 2.66 | 0.43 |
BUN, mg/dL | 64.9 ± 16.0 | 64.7 ± 15.6 | 65.5 ± 17.3 | 0.83 |
Serum calciumb, mg/dL | 9.33 ± 0.67 | 9.33 ± 0.67 | 9.35 ± 0.70 | 0.87 |
Serum phosphate, mg/dL | 5.3 (4.73–5.3) | 5.4 (4.9–6.3) | 5.0 (4.0–5.45) | 0.001 |
BMI, kg/m2 | 21.6 ± 3.50 | 21.8 ± 3.28 | 21.4 ± 4.07 | 0.25 |
Serum albumin, g/dL | 3.95 (3.72–4.10) | 4.0 (3.8–4.1) | 3.9 (3.65–4.1) | 0.22 |
LDL-cholesterol, mg/dL | 75 (57.3–94.5) | 73 (57–93) | 77 (60.5–99) | 0.69 |
CRP, mg/dl | 0.07 (0–0.35) | 0.05 (0–0.14) | 0.30 (0.02–0.77) | 0.003 |
History of CADa | 31 (27%) | 22 (25%) | 9 (31%) | 0.63 |
History of atrial fibrillationa | 14 (12%) | 10 (11%) | 4 (14%) | 0.22 |
History of diabetes mellitus | 38 (33%) | 28 (32%) | 10 (34%) | 0.82 |
History of hypertensiona | 100 (86%) | 73 (84%) | 27 (93%) | 0.35 |
History of dyslipidemiaa | 27 (23%) | 20 (23%) | 7 (24%) | 1.00 |
History of CV events | 48 (41%) | 34 (39%) | 14 (48%) | 0.38 |
History of gastrectomya | 6 (5.2%) | 3 (3.4%) | 3 (10%) | 0.16 |
History of malignancya | 5 (4.3%) | 4 (4.6%) | 1 (3.5%) | 0.34 |
Positive fecal occult blooda | 19 (16%) | 12 (16%) | 7 (25%) | 0.39 |
History of liver disordersa | 14 (12%) | 10 (12%) | 4 (14%) | 0.75 |
Recent hospitalizationa | 8 (6.9%) | 4 (4.6%) | 4 (14%) | 0.11 |